StockNews.com upgraded shares of Innoviva (NASDAQ:INVA – Free Report) from a hold rating to a buy rating in a research note ...

StockNews.com downgraded shares of Innoviva (NASDAQ:INVA – Free Report) from a buy rating to a hold rating in a research report sent to investors on Saturday morning. Separately, Scotiabank assumed ...

Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as ...

GSK also manufactures Advair, Anoro Ellipta and Arnuity Ellipta for asthma. It also manufactures Augmentin, an antibiotic used to treat various bacterial infections. GSK’s exit and change of model ...

Innoviva is entitled to receive royalties from GSK on sales of RELVAR ® /BREO ® ELLIPTA ® and ANORO ® ELLIPTA ®. Innoviva’s other innovative healthcare assets include infectious disease and ...

Some GSK also manufactures Advair, Anoro Ellipta and Arnuity Ellipta for asthma. Their exit and change of model have put pressure on patients who now spend more than 100 per cent more than the usual ...